Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Journal of the International AIDS Society|November 14, 2014
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST studyFederico Garcia, Eva Poveda, Maria Jesús Pérez-Elías, et al.
Plos One|July 14, 2022
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Plos One|November 21, 2024
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2021
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network CohortJuan Berenguer, Cristina Díez, María Martín-Vicente, et al.
Cellular & Molecular Immunology|July 22, 2021
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infectionAlberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
Clinical and Translational Medicine|April 13, 2022
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous responseAlberto Pérez-Gómez, Carmen Gasca-Capote, Joana Vitallé, et al.
Retrovirology|August 15, 2012
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapyGilberto Betancor, César Garriga, Maria C Puertas, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of the International AIDS Society|November 14, 2014
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST studyFederico Garcia, Eva Poveda, Maria Jesús Pérez-Elías, et al.
Plos One|July 14, 2022
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Plos One|November 21, 2024
Correction: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patientsMaría Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana Serna-Gallego, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2021
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network CohortJuan Berenguer, Cristina Díez, María Martín-Vicente, et al.
Cellular & Molecular Immunology|July 22, 2021
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infectionAlberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
Clinical and Translational Medicine|April 13, 2022
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous responseAlberto Pérez-Gómez, Carmen Gasca-Capote, Joana Vitallé, et al.
Retrovirology|August 15, 2012
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapyGilberto Betancor, César Garriga, Maria C Puertas, et al.
Pageof 15